Genzyme Corp. (GENZ) Approves $1.5 Billion Stock Buyback

Article Stock Quotes (1) Comments (0)

Genzyme Corp. (Nasdaq: GENZ) has authorized the repurchase of up to $1.5 billion or 20 million of the company's outstanding common shares over the next three years. The share repurchase program is designed to reduce the dilutive effect of the company's equity compensation programs, and it reflects Genzyme's confidence in the long-term value of its common stock.

You May Also Be Interested In

• Hatteras Financial (HTS) Approves 10M Buyback Plan
• CorVel (CRVL) Approves $14M Buyback Plan
• Smith & Wesson (SWHC) Announces Debt Exchange, $100M Buyback Plan

Create E-mail Alert Related Categories

Stock Buybacks

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?